9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine and Germinoblastoma

9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine has been researched along with Germinoblastoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hanzalová, J; Holý, A; Otová, B; Starková, J; Votruba, I; Zápotocký, M	1

Other Studies

1 other study(ies) available for 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine and Germinoblastoma

Article	Year
Experimental therapy with 9-[2-(phosphonomethoxy)ethyl]-2,6-diaminopurine (PMEDAP): origin of resistance. Folia biologica, 2007, Volume: 53, Issue:3 Topics: Adenine; Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Lymphoma; Male; Multidrug Resistance-Associated Proteins; Neoplasm Transplantation; Organ Size; Rats; Rats, Sprague-Dawley; Transcriptional Activation	2007

Article

Year

Experimental therapy with 9-[2-(phosphonomethoxy)ethyl]-2,6-diaminopurine (PMEDAP): origin of resistance.

Folia biologica, 2007, Volume: 53, Issue:3

Topics: Adenine; Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Lymphoma; Male; Multidrug Resistance-Associated Proteins; Neoplasm Transplantation; Organ Size; Rats; Rats, Sprague-Dawley; Transcriptional Activation

2007